Retrospective evaluation of borderline ovarian tumors: single center experience of 183 cases.
Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Education and Research Hospital, 06230, Hamamonu, Ankara, Turkey.
- Published Article
Archives of gynecology and obstetrics
- Publication Date
Jan 01, 2015
In our study, we evaluated a large data pool of 183 patients diagnosed with borderline epithelial ovarian tumors. BOTs have a relatively better prognosis than invasive epithelial ovarian cancer. Surgery with proper staging is the cornerstone of treatment. Patients with BOTs at the early stage can undergo fertility sparing surgery with close follow-up.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/25047273